Date published: 2026-1-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

Melan-A Inhibitors

Melan-A inhibitors belong to a distinct chemical class characterized by their capacity to interact with and modulate the activity of the Melan-A protein. Melan-A, also known as MART-1 (Melanoma Antigen Recognized by T cells 1), is a melanocyte-specific protein expressed in the skin and other melanin-producing tissues. This protein plays a crucial role in melanin synthesis and pigmentation, which is responsible for the coloration of skin, hair, and eyes in humans. Melan-A inhibitors are designed to influence the function of this protein through various mechanisms, with the goal of manipulating melanin production for possible applications. Chemically, Melan-A inhibitors encompass a diverse range of compounds, often featuring unique structural motifs that allow them to selectively target and bind to specific regions of the Melan-A protein. These inhibitors can interfere with key enzymatic steps in the melanin synthesis pathway, thereby impacting the production of melanin pigments. Some inhibitors function by blocking the interaction between Melan-A and its substrate molecules, while others might inhibit downstream signaling pathways that contribute to melanin synthesis regulation. Researchers have explored the design and synthesis of Melan-A inhibitors in order to gain a deeper understanding of melanogenesis and its molecular underpinnings.

Given the pivotal role of Melan-A in melanin biosynthesis, inhibitors targeting this protein could offer valuable insights into the regulation of pigmentation processes and applications in various fields. Understanding the interactions between these inhibitors and the Melan-A protein can pave the way for novel approaches in the realm of skin biology and pigment-related research. Ongoing studies in this area continue to uncover the precise mechanisms through which Melan-A inhibitors influence melanin synthesis, contributing to the broader knowledge of pigmentation control and revealing new avenues for future scientific exploration.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

A BRAF kinase inhibitor used for melanomas with specific BRAF mutations.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$141.00
$260.00
$278.00
$411.00
$12485.00
6
(1)

Another BRAF inhibitor targeting certain BRAF mutations in melanoma.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

A MEK inhibitor often combined with BRAF inhibitors for BRAF-mutated melanoma.

Cobimetinib

934660-93-2sc-507421
5 mg
$270.00
(0)

A MEK inhibitor used in combination with BRAF inhibitors for melanoma.

MEK 162

606143-89-9sc-488879
10 mg
$306.00
(0)

A MEK inhibitor used with encorafenib (a BRAF inhibitor) for unresectable or metastatic melanoma.

Encorafenib

1269440-17-6sc-507422
1 mg
$115.00
(0)

A BRAF inhibitor used with binimetinib to target specific BRAF mutations in melanoma.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$29.00
$82.00
$420.00
$1897.00
$3021.00
5
(1)

A MEK inhibitor showing promise for neurofibromatosis type 1-related plexiform neurofibromas associated with melanoma.